The presenter expresses a positive outlook on AbbVie, indicating it as a strong buy based on its recovery.
ABBV is included in a list of strong dividend stocks, suggesting a positive outlook for its long-term growth potential.
The mention of ABV is brief and lacks a clear recommendation, indicating an informational context rather than a strong buy or sell signal.
The presenter mentions ABBV as having a good setup for a short-term trade, indicating a positive outlook.
1 of 7 days measured · shaded = no mentions
The blue horizontal line marks the plate's own 30-day score, shown above — it is not an average of the points around it. Each point is that single day's own score, computed the same way but over one day instead of the whole window.
First in this window: Bulls On Wall Street · Aug 18, 2026
| BBulls On Wall Street384k subs | 2 | 15.24 | NEUT | Not stated |
| BStockCharts TV144k subs | 1 | 10.49 | BULL | 6M+ |
| CGenExDividendInvestor87k subs | 1 | 8.47 | BULL | 6M+ |
| This Could Be the Market's Biggest Risk in SeptemberWatch on YouTube ↗ | StockCharts TV | Aug 20, 2026 | 10.49 |
| My 200-Year Dividend Dynasty Trust: Insane $$$ For My Heirs!Watch on YouTube ↗ | GenExDividendInvestor | Sep 5, 2026 | 8.47 |
| Stay Out of the Middle: The Trade That Wrecks People in Range MarketsWatch on YouTube ↗ | Bulls On Wall Street | Aug 18, 2026 | 8.47 |
| Stop Saying Cash Is a Position — the Rotation Is OnWatch on YouTube ↗ | Bulls On Wall Street | Aug 23, 2026 | 6.77 |